<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-0807</journal-id>
<journal-title><![CDATA[Revista de la Universidad Industrial de Santander. Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Univ. Ind. Santander. Salud]]></abbrev-journal-title>
<issn>0121-0807</issn>
<publisher>
<publisher-name><![CDATA[Universidad Industrial de Santander]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-08072011000200005</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Antifungal, cytotoxic and chemical analyses of essential oils of Lippia origanoides H.B.K grown in Colombia]]></article-title>
<article-title xml:lang="es"><![CDATA[Actividad antifúngica, citotó;xica y composición química de aceites esenciales de Lippia origanoides H.B.K recolectadas en Colombia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Betancur-Galvis]]></surname>
<given-names><![CDATA[Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[Bibiana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Baena]]></surname>
<given-names><![CDATA[Armando]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruíz-Nova]]></surname>
<given-names><![CDATA[Carlos Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[Elena]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mesa-Arango]]></surname>
<given-names><![CDATA[Ana Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad de Antioquia Facultad de Medicina Grupo de Investigación Dermatológicas]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidad de Antioquia Facultad de Medicina Grupo  Infección y Cáncer]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Instituto Nacional de Salud Grupo de Microbacterias ]]></institution>
<addr-line><![CDATA[Bogotá, D.C. ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Universidad Industrial de Santander Centro de Investigación en Biomolécular ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2011</year>
</pub-date>
<volume>43</volume>
<numero>2</numero>
<fpage>141</fpage>
<lpage>148</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-08072011000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-08072011000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-08072011000200005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Introduction: Aspergillus fumigatus is most commonly associated to invasive aspergillosis. Strong antifungal activity against A. fumigatus of L. origanoides essential oil gives a new added value to this natural product from Boyacá-Colombia. Aims: The increase in fungal infections, the development of resistance and toxicity of wide-spectrum antifungals have led to a constant search for therapeutic alternatives. The chemical composition, antifungal and cytotoxic activity of nine essential oils obtained from L. origanoides were evaluated and the relationship between the antifungal activities of the oil and of its major components were explored. Methods and Results: Antifungal activity was determined following the protocols AFST-EUCAST for Candida krusei and C. parapsilosis, and CLSI-M38A for Aspergillus fumigatus and A. flavus. The GC-MS analysis identified three chemotypes: thymol, carvacrol and p-cymene/trans-beta-caryophyllene. The essential oil of the thymol chemotype was the most active in antifungal assays with MIC values of 157.5, 198.4, 125 and 31 &#956;g ml-1 against C. parapsilosis, C. krusei, A. flavus and A. fumigatus, respectively. The major components carvacrol and thymol were not active against A. fumigatus at concentrations below 157.5 &#956;g ml-1. In general, the oils were not cytotoxic. Conclusions: The essential oil of the thymol chemotype of L. origanoides from the region of Boyacá- Colombia showed the highest antifungal activity against A. fumigatus among all the oils and major components tested. Salud UIS 2011; 43 (2): 141-148]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Introducción: La infección por el hongo Aspergillus fumigatus está más comúnmente asociada a la aspergilosis invasiva. La fuerte actividad antimicótica del aceite esencial de L. origanoides contra A. fumigatus ha dado un nuevo valor agregado a este producto natural de Boyacá-Colombia. Objetivo: El aumento de las infecciones por hongos, el desarrollo de la resistencia y la toxicidad de los antifúngicos de amplio espectro han llevado a una constante búsqueda de alternativas terapéuticas. En este estudio fueron evaluados la composición química, la actividad antifúngica y citotóxica de nueve aceites esenciales obtenidos de L. origanoides; y la relación entre la actividad antifúngica de los aceites con respecto a la presencia de sus principales componentes. Métodos y Resultados: La actividad antifúngica se determinó siguiendo los protocolos AFST-EUCAST para Candida krusei y C. parapsilosis; y CLSI M38A para Aspergillus fumigatus y A. flavus. El análisis por GC-MS identificó tres quimiotipos: carvacrol timol y p-cymene/trans-beta-caryophyllene. El aceite esencial del quimiotipo timol fue el más activo en los ensayos antifúngicos con valores de MIC de 157,5, 198,4, 125 y 31 mg ml-1 frente a C. parapsilosis, C. krusei, A. flavus y A. fumigatus, respectivamente. El carvacrol y el timol, los principales componentes, no fueron activos frente a A. fumigatus en concentraciones inferiores a 157,5 g / ml-1. En general, los aceites no fueron citotóxicos. Conclusiones: El aceite esencial de L origanoides, quimiotipo timol, de la región de Boyacá-Colombia presentó la mayor actividad antifúngica frente a A. fumigatus entre todos los aceites evaluados; igualmente, sus principales componentes fueron los más activos en comparación a los otros quimiotipos. Salud UIS 2011; 43 (2): 141-148]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Lippia origanoides]]></kwd>
<kwd lng="en"><![CDATA[essential oil]]></kwd>
<kwd lng="en"><![CDATA[antifungal activity]]></kwd>
<kwd lng="en"><![CDATA[cytotoxicity]]></kwd>
<kwd lng="en"><![CDATA[monoterpenes]]></kwd>
<kwd lng="es"><![CDATA[Lippia origanoides]]></kwd>
<kwd lng="es"><![CDATA[aceite esencial]]></kwd>
<kwd lng="es"><![CDATA[actividad antifúngica]]></kwd>
<kwd lng="es"><![CDATA[citotoxicidad]]></kwd>
<kwd lng="es"><![CDATA[monoterpenos]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[   <font size="2" face="Verdana">     <p align="center"><font size="4"><b>Antifungal, cytotoxic and chemical    <br> analyses of essential oils of <i>Lippia    <br> origanoides</i> H.B.K grown in Colombia</b></font></p>      <p align="center">Liliana Betancur-Galvis<sup>1</sup>, Bibiana Zapata<sup>1</sup>, Armando Baena<sup>2</sup>, Juan Bueno<sup>3</sup>,    <br> Carlos Alberto Ru&iacute;z-Nova<sup>2</sup>, Elena Stashenko<sup>4</sup>, Ana Cecilia Mesa-Arango<sup>1</sup></p> 	     <p align="left">1. Grupo de Investigaci&oacute;n Dermatol&oacute;gica (GRID), Facultad de Medicina, Universidad de Antioquia    <br> 2. Grupo Infecci&oacute;n y C&aacute;ncer, Facultad de Medicina, Universidad de Antioquia.    <br>  3. Grupo de Micobacterias, Instituto Nacional de Salud, Bogot&aacute;, D.C., Colombia    <br> 4. Centro de Investigaci&oacute;n en Biomol&eacute;culas, CIBIMOL. Universidad Industrial de Santander    ]]></body>
<body><![CDATA[<br> <b>Correspondencia:</b> Liliana Betancur-Galvis. Spc, MsC, PhD. Chemist. Group of Investigative Dermatology (GRID), School of Medicine, University of Antioquia, Medell&iacute;n, Colombia.    <br> Cra. 51D &#35; 62 -29 Lab 283. Phone: (+574) 2196064. A.A. 1226. Medell&iacute;n, Antioquia, E-mail: <a href="mailto:labeta@quimbaya.udea.edu.co">labeta@quimbaya.udea.edu.co</a>.    <br> <b>Recibido:</b> 14 de febrero 2011- <b>Aceptado:</b> 10 de agosto de 2011</p>  <hr>      <p align="center"><font size="3"><b>ABSTRACT</b></font></p>      <p align="justify"><b>Introduction:</b> <i>Aspergillus fumigatus</i> is most commonly associated to invasive aspergillosis. Strong antifungal activity against <i>A. fumigatus</i> of <i>L. origanoides</i> essential oil gives a new added value to this natural product from Boyac&aacute;-Colombia. <b>Aims:</b> The increase in fungal infections, the development of resistance and toxicity of wide-spectrum antifungals have led to a constant search for therapeutic alternatives. The chemical composition, antifungal and cytotoxic activity of nine essential oils obtained from <i>L. origanoides</i> were evaluated and the relationship between the antifungal activities of the oil and of its major components were explored. <b>Methods and Results:</b> Antifungal activity was determined following the protocols AFST-EUCAST for <i>Candida krusei</i> and <i>C. parapsilosis</i>, and CLSI-M38A for <i>Aspergillus fumigatus</i> and <i>A. flavus</i>. The GC-MS analysis identified three chemotypes: thymol, carvacrol and <i>p</i>-cymene/<i>trans</i>-beta-caryophyllene. The essential oil of the thymol chemotype was the most active in antifungal assays with MIC values of 157.5, 198.4, 125 and 31 &mu;g ml-1 against <i>C. parapsilosis</i>, <i>C. krusei</i>,  <i>A. flavus</i> and <i>A. fumigatus</i>, respectively. The major components carvacrol and thymol were not active against <i>A. fumigatus</i> at concentrations below 157.5 &mu;g ml-1. In general, the oils were not cytotoxic.  <b>Conclusions:</b> The essential oil of the thymol chemotype of <i>L. origanoides</i> from the region of Boyac&aacute;- Colombia showed the highest antifungal activity against <i>A. fumigatus</i> among all the oils and major components tested. <b><i>Salud UIS</i> 2011; 43 (2): 141-148</b></p> 	     <p align="justify"><b>Keywords:</b> <i>Lippia origanoides</i>, essential oil, antifungal activity, cytotoxicity, monoterpenes</p>      <p align="center"><font size="3"><b>Actividad antif&uacute;ngica, citot&oacute;xica y composici&oacute;n    <br> qu&iacute;mica de aceites esenciales de Lippia    <br> origanoides H.B.K recolectadas en Colombia</b></font></p>      <p align="center"><font size="3"><b>RESUMEN</b></font></p> 	     ]]></body>
<body><![CDATA[<p align="justify"><b>Introducci&oacute;n:</b> La infecci&oacute;n por el hongo <i>Aspergillus fumigatus</i> est&aacute; m&aacute;s com&uacute;nmente asociada a la aspergilosis invasiva. La fuerte actividad antimic&oacute;tica del aceite esencial de <i>L. origanoides</i> contra <i>A. fumigatus</i> ha dado un nuevo valor agregado a este producto natural de Boyac&aacute;-Colombia. <b>Objetivo:</b> El aumento de las infecciones por hongos, el desarrollo de la resistencia y la toxicidad de los antif&uacute;ngicos de amplio espectro han llevado a una constante b&uacute;squeda de alternativas terap&eacute;uticas. En este estudio fueron evaluados la composici&oacute;n qu&iacute;mica, la actividad antif&uacute;ngica y citot&oacute;xica de nueve aceites esenciales obtenidos de <i>L. origanoides</i>; y la relaci&oacute;n entre la actividad antif&uacute;ngica de los aceites con respecto a la presencia de sus principales componentes.  <b>M&eacute;todos y Resultados:</b> La actividad antif&uacute;ngica se determin&oacute; siguiendo los protocolos AFST-EUCAST para <i>Candida krusei</i> y <i>C. parapsilosis</i>; y CLSI M38A para <i>Aspergillus fumigatus</i> y <i>A. flavus</i>. El an&aacute;lisis por GC-MS identific&oacute; tres quimiotipos: carvacrol timol y <i>p</i>-cymene/<i>trans</i>-beta-caryophyllene. El aceite esencial del quimiotipo timol fue el m&aacute;s activo en los ensayos antif&uacute;ngicos con valores de MIC de 157,5, 198,4, 125 y 31 mg ml-1 frente a <i>C. parapsilosis</i>, <i>C. krusei</i>, <i>A. flavus</i> y <i>A. fumigatus</i>, respectivamente. El carvacrol y el timol, los principales componentes, no fueron activos frente a <i>A. fumigatus</i> en concentraciones inferiores a 157,5 g / ml-1. En general, los aceites no fueron citot&oacute;xicos. <b>Conclusiones:</b> El aceite esencial de <i>L origanoides</i>, quimiotipo timol, de la regi&oacute;n de Boyac&aacute;-Colombia present&oacute; la mayor actividad antif&uacute;ngica frente a <i>A. fumigatus</i> entre todos los aceites evaluados; igualmente, sus principales componentes fueron los m&aacute;s activos en comparaci&oacute;n a los otros quimiotipos. <b><i>Salud UIS</i> 2011; 43 (2): 141-148</b></p> 	     <p align="justify"><b>Palabras Clave:</b> <i>Lippia origanoides</i>, aceite esencial, actividad antif&uacute;ngica, citotoxicidad, monoterpenos</p>  <hr>      <p align="center"><font size="3"><b>INTRODUCTION</b></font></p>      <p align="justify">The AIDS epidemic, chemotherapy in cancer patients, neutropenia and immunosuppressant therapies in recipients with transplants have increased the number of cases of mycotic infections<sup>1,2</sup>. Species of the genera <i>Candida</i>, <i>Cryptococcus, Aspergillus, Histoplasma, Rhizopus, Mucor, Acremonium,</i> and <i>Fusarium</i> are the most frequent causes of these infections<sup>1</sup>. Although <i><i>C. albicans</i></i> is the most frequent species, the prevalence of other non-<i>albicans</i> species has been increasing recently<sup>3</sup>. <i>Aspergillus</i> infections have also grown in importance in the last years<sup>4,1</sup>. <i>A. fumigatus</i> and <i>A. flavus</i> are the most widespread causes of invasive aspergillosis<sup>4</sup>.    <br> The development of resistance of some species to the antifungal drugs available and the toxicity of widespectrum antifungals, such as amphotericin B, have led to a constant search for therapeutic alternatives<sup>2</sup>. Many aromatic plants are frequently used in traditional medicine as antimicrobial agents, and the essential oils recovered from some of them have demonstrated antibacterial and antifungal effects<sup>5,6</sup>. In addition, some oils have shown activity against fluconazole and itraconazole resistant <i>Candida</i> spp.<sup>5</sup>    <br> <i>Lippia origanoides</i> H.B.K. (<i>Verbenaceae</i>) is a shrub up to 3 m tall that grows wild in Central America (Mexico, Guatemala, Cuba) and northern South America (Guiana, Venezuela, Brazil, Colombia)<i>7,8</i>. In Colombia, it is found at altitudes between 500 and 800 m in several Andean states and in the northern peninsula of Guajira. Its green oval leaves are employed as a condiment (due to their thymol and carvacrol content) and as a traditional medicine (flower and leaf infusions)<sup>9,8</sup>. In Mexico, <i>L. origanoides</i> is called &quot;oregano&quot;, and the Mexican Pharmacopoeia recognizes it as a substitute for common oregano – <i>L. graveolens</i> Kunth<sup>8</sup>. Essential oils with high thymol content have showed MIC values of 3.3 mg ml-1 against <i>C. albicans</i><sup>10</sup>. Oliveira <i>et al</i>.<sup>8</sup> studied the antifungal activity of the essential oil of <i>L. origanoides</i> which presented high carvacrol content and showed active against human pathogenic fungi of genera <i>Candida</i>.    <br> The composition and biological activity of essential oils from <i>L. origanoides</i> H.B.K. grown in Colombia have not been studied. In the present work, the chemical composition, antifungal and cytotoxic activity of nine essential oils obtained from <i>L. origanoides</i>, collected from four Colombian regions were evaluated and the relationship between the antifungal activities of the oil and of its major components were explored.</p>      <p align="center"><font size="3"><b>MATERIALS AND METHODS</b></font></p>      <p align="justify"><b>Plant material and essential oil extraction</b>    <br> Nine samples (1 kg each) of <i>L. origanoides</i> stems and leaves were collected from four regions in Colombia, as part of a survey conducted by CENIVAM, a Research Center devoted to the study of aromatic plants and essential oils in Colombia. The taxonomic identification of the botanical samples was performed by Dr. Jos&eacute; Lu&iacute;s Fern&aacute;ndez at &quot;Herbario Nacional de Colombia (COL)&quot;, Institute of Natural Sciences, School of Sciences, &quot;Universidad Nacional de Colombia&quot; (Bogot&aacute;), where exsiccate of each plant remain as permanent samples. The essential oils were extracted from dried <i>L. origanoides</i> stems and leaves (300 g) by microwave-assisted hydrodistillation as described previously<sup>11</sup>. Anhydrous sodium sulfate (Merck, Darmstadt, Germany) was added as a drying agent to the decanted essential oil. The voucher numbers, the region of plant collection, date of collection and the codes assigned to the essential oils obtained are presented in (<a href="img/revistas/suis/v43n2/v43n2a05t1.jpg" target="_blank">Table 1</a>).    ]]></body>
<body><![CDATA[<br> <i>Analysis of essential oils</i> -Compound identification was based on mass spectra (EI, 70 eV), obtained with a gas chromatograph (Agilent Technologies 6890 Plus, Palo Alto, CA, USA), equipped with a mass selective detector (Agilent Technologies 5973), a split/splitless injector (split ratio 1:50), and a data system (HP ChemStation 1.05) with WILEY 138K, NIST 2002 and QUADLIB 2004 mass spectra libraries, as described previously<sup>12</sup>. Individual components were identified by comparing their retention indices<sup>11</sup> determined using a linear scale on the DB-5MS (60m x 0.25mm x 0.25&mu;L, J and W Scientific, Folsom, CA, USA) column, and the mass spectra of each GC component to those of standard substances (Sigma- Aldrich, USA; <a href="img/revistas/suis/v43n2/v43n2a05t2.jpg" target="_blank">Table 2</a>). The hydrodistillation process ensured endotoxin-free material, since such a technique is unable to remove high-molecular mass molecules such as endotoxins (10 kDa) from plant material, and the molecular weight of essential oil components does not surpass 0.3 kDa. Stock solutions of oils were prepared in DMSO and frozen at -70&deg;C until required.</p>      <p align="justify"><b>Monoterpenes and drug</b>    <br> Thymol, carvacrol, <i>p</i>-cymene, <i>trans</i>-beta-caryophyllene, gamma-terpinene and beta-myrcene and other standard substances for the analysis of essential oils were from Sigma (Chemical Company St Louis, MO, USA). Stock solutions of both oils and monoterpenes were prepared in DMSO for cytotoxicity and antifungal assays. Amphotericine B and itraconazole were from Sigma.</p>      <p align="justify"><b>Antifungal activity assay</b>    <br> The antifungal activity of the oils and monoterpenes was evaluated following the Clinical and Laboratory Standards Institute M38-A protocol<sup>13</sup> for filamentous fungi, and the standard method proposed by the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (EUCAST)<sup>14</sup> for fermentative yeasts, as described previously<sup>12</sup>. <i>Candida parapsilosis</i> (ATCC 22019), <i>C. krusei</i> (ATCC 6258), <i>Aspergillus flavus</i> (ATCC 204304) and <i>A. fumigatus</i> (ATCC 204305) served to evaluate antifungal activity. For the EUCAST method, MIC were determined after 24 hours of incubation, and defined as the lowest concentration that resulted in a 90&#37; reduction of growth. For the CLSI M38-A method, the MICs were determined after 48 hours of incubation, and defined as the lowest dilution of essential oils that resulted in total inhibition of visible growth. Susceptibility testing was performed in duplicate in three different assays. Essential oils and monoterpenes were considered active when they presented MIC values below 500 &mu;g ml-1.</p>      <p align="justify"><b>Cytotoxicity assay</b>    <br> <i>Cercopithecus aethiops</i> African green monkey kidney cells (Vero cell line ATCC CCL-81) were used. The cytotoxicity of the essential oils and their major components were examined <i>in vitro</i> with an MTT (dimethylthiazol-2-yl&#93;-2,5-diphenyl tetrazolium bromide) (Sigma, New Jersey, USA) assay as described in Mesa-Arango <i>et al.</i><sup>12</sup>. The concentration of compounds that induces 50&#37; growth inhibition in 48h was expressed as IC<sub>50</sub>. Vincristine was used as positive control (Sigma-Aldrich, Co, MO, USA).    <br> <i>Data analysis</i> - The IC<sub>50</sub> values for each compound were obtained by lineal regression analysis of the dose– response curves generated from the absorbance data with the statistical package R (Development Core Team, Vienna, Austria, 2008). IC<sub>50</sub> values are expressed as the Mean &plusmn; S.E.M. of at least four dilutions performed in quadruplicates in two different assays. MIC values are expressed as geometric means (GM-MIC) of tests performed in duplicate in three different assays against each of the fungal species.    <br> To test the association of oil activity with chemical composition of the major components, the Cox model with the determination of the hazard ratio was applied; a 95&#37; confidence interval was adopted. Statistical analyses were conducted using the statistical package R (Development Core Team, Vienna, Austria, 2008).</p>      <p align="center"><font size="3"><b>RESULTS</b></font></p>      ]]></body>
<body><![CDATA[<p align="justify">The present work evaluated the chemical composition of nine essential oils obtained from <i>L. origanoides</i> plants, collected from four Colombian regions (<a href="img/revistas/suis/v43n2/v43n2a05t1.jpg" target="_blank">Table 1</a>). The various components were identified by comparing their retention indices (RI)<sup>11</sup>, and the mass spectrum of each GC component to those of standard substances. <a href="img/revistas/suis/v43n2/v43n2a05t2.jpg" target="_blank">Table 2</a> lists the major components (&gt;1&#37;) found during the chromatographic analysis of essential oils. Kovàts retention indices (I<sub>k</sub>), used as complementary identification criteria, were obtained at polar (DBWAX) and non-polar (DB-5) stationary phases. The chromatographic analysis of the essential oils evaluated here detected ca. 50 compounds (data not shown). GC/ MS analyses permitted to positively identify 40 oil constituents. The GC/MS analyses showed that the major constituents of the oils were monoterpene hydrocarbons and phenolic monoterpenes, but their concentration in the oils varied greatly. Quantitative oil differences were clear for seven compounds: <i>trans</i>-beta-caryophyllene, alpha-humulene, the two isomeric phenols, carvacrol and thymol, and their precursor gamma-terpinene and <i>p</i>-cymene, and beta-myrcene. GC/MS analysis of the oils revealed the presence of three chemotypes: thymol, carvacrol and <i>p</i>-cymene/<i>trans</i>-beta-caryophyllene (<a href="img/revistas/suis/v43n2/v43n2a05t1.jpg" target="_blank">Tables 1</a> and  <a href="img/revistas/suis/v43n2/v43n2a05t2.jpg" target="_blank">2</a>). Among the thymol-chemotype oils, the 6F oil obtained from plants collected in the Department of Boyac&aacute; showed the highest thymol concentration. The major components found in 6F oil were thymol (59.7&#37;), followed by carvacrol (12.2&#37;), <i>p</i>-cymene (8.8&#37;), and gamma-terpinene (4.5&#37;). In the carvacrolchemotype oils, the 5E oil obtained from plants collected in the Department of Santander showed the highest carvacrol concentration. The major components found in 5E oil were carvacrol (46.2&#37;), <i>p</i>-cymene (12.0&#37;), thymol (9.5&#37;), and gamma-terpinene (9.5&#37;). The 9I oil showed carvacrol and thymol contents of 38.8&#37; and 15.1&#37;, respectively. In the <i>p</i>-cimene/<i>trans</i>-beta- caryophyllene chemotype oils, p-cymene was the main constituent (&#126;13.5&#37;), followed by <i>trans</i>-betacaryophyllene (&#126;10.4&#37;), alpha-phellandrene (&#126;9.3&#37;), 1,8-cineol (&#126;6.6&#37;) and alpha-humulene (&#126;5.9 &#37;).    <br> The results of the oils and the cytotoxic and antifungal activities of some of their major components are presented in (<a href="img/revistas/suis/v43n2/v43n2a05t3.jpg" target="_blank">Table 3</a>). According to the significance threshold determined by the National Cancer Institute (USA) for crude extracts (inhibitory concentration 50 IC<sub>50</sub> &lt;30 &mu;g ml-1)<sup>5</sup>, the oils and monoterpenes evaluated were not cytotoxic on the Vero non-tumoural cell line. A dose-dependent inhibition on the growth of Vero cells, with <i>R</i><sup>2</sup> determination coefficients of linear regression greater than 7.5, was observed for monoterpenes and oils (<a href="img/revistas/suis/v43n2/v43n2a05t3.jpg" target="_blank">Table 3</a>). The results of the antifungal activity assays of <i>L. origanoides</i> oils against <i>Candida</i> and <i>Aspergillus</i> species are presented in (<a href="img/revistas/suis/v43n2/v43n2a05t3.jpg" target="_blank">Table 3</a>). The MIC values for the reference antifungal drugs, amphotericine B and itraconazole used as positive controls were within the values established using the AFST-EUCAST and CLSIM38- A protocols (<a href="img/revistas/suis/v43n2/v43n2a05t3.jpg" target="_blank">Table 3</a>).</p>      <p align="justify">As can be observed in (<a href="img/revistas/suis/v43n2/v43n2a05t3.jpg" target="_blank">Table 3</a>), only the 4D oil did not show activity for the fungi&#95;evaluated. The 3C oil showed the highest antifungal activity against <i>C. parapsilosis</i>, <i>C. krusei</i> and <i>A. flavus</i> but not against <i>A. fumigatus</i> with MG-MIC values of 157, 198, 125, 63 &mu;g ml-1, respectively. The 7G oil showed the highest antifungal activity against <i>A. fumigatus</i>, with MG-MIC value of 31 &mu;g ml-1. In general, <i>A. fumigatus</i> was more sensitive to essential oils than <i>A. flavus</i> and <i>Candida</i> species. The monoterpenoids, <i>trans</i>-beta-caryophyllene, gammaterpinene, and beta-myrcene did not show activity at concentrations of 500 &mu;g ml-1 for the fungi evaluated. Among the six compounds tested, carvacrol and thymol were the most active against the fungi evaluated.    <br> To examine the correlation between oil activity and the major components in situ, percentage composition of the major components of the oils were screened with oil antifungal activity in a Cox model. (<a href="img/revistas/suis/v43n2/v43n2a05t4.jpg" target="_blank">Table 4</a>) shows the results of these analyses that were adjusted for each fungus. Thymol and carvacrol were the major components that were associated with oil antifungal activity for <i>Candida</i> species. For <i>A. fumigatus</i> and <i>A. flavus</i>, thymol/beta-myrcene and thymol/carvacrol/pcymene were the monoterpenoids associated with oil antifungal activity, respectively.</p>      <p align="center"><font size="3"><b>DISCUSSION</b></font></p>      <p align="justify"><i>Lippia origanoides</i> H.B.K. Fam. (<i>Verbenaceae</i>) is a slender, very aromatic shrub<sup>7</sup>. Oliveira <i>et al.</i><sup>8</sup> reported the composition of <i>L. origanoides</i> essential oil from Oriximin&aacute; - Brazil, in which carvacrol was the main constituent (38&#37;), followed by thymol (18&#37;) and <i>p</i>-cymene (10&#37;). Rojas <i>et al.</i><sup>15</sup> compared the compositions of <i>L. origanoides</i> oils from leaves collected during the rainy and dry seasons in Venezuela; thymol (61.9 and 44.7&#37;) and carvacrol (7.9 and 16.8&#37;) were the main components in these oils, respectively. Oliveira <i>et al.</i><sup>8</sup> suggests the existence of two different chemotypes for this species – thymol and carvacrol.    <br> In the present study, the chemical composition of nine essential oils obtained of <i>L. origanoides</i> collected from four Colombian regions were evaluated. The GC/MS analysis of the oils revealed the presence of three chemotypes: thymol, carvacrol, and <i>p</i>-cymene/ <i>trans</i>-beta-caryophyllene. The <i>p</i>-cymene/<i>trans</i>-betacaryophyllene chemotype was reported previously<sup>16</sup>, and it was observed that the composition of the oil was not caused by microclimate or geobotanical differences. The findings suggest that there are different chemotypes for this species, in a way similar to what happens with Lippia alba<sup>5</sup>. In spite of the existence of several <i>L. origanoides</i> chemotypes in Colombia, there had been no evaluation of the antifungal and cytotoxic activity of their essential oils.    <br> With respect to antifungal activity there is no agreement on the acceptance level of activity for plant material when compared to standard drugs<sup>12</sup>. Duarte <i>et al.</i><sup>17</sup> indicated a strong activity of <i>L. alba</i> essential oils against <i>C. albicans</i> with a MIC value of 60 &mu;g ml-1, when nistatin was used as positive control (MIC of 50 &mu;g ml-1). According to these criteria the 7G oil was very active against <i>A. fumigatus</i> with a MIC value of 31 &mu;g ml-1. The 3C oil showed a strong antifungal activity against the four fungi evaluated. Both oils were thymol chemotypes. In contrast the oils 2B and 4D, <i>p</i>-cymene-/ <i>trans</i>-beta-caryophyllene chemotype, showed moderate and weak activity, respectively.    <br> Studies of antifungal activity of essential oils with high thymol and carvacrol have been carried out on <i>Candida</i> species. Botelho <i>et al.</i><sup>18</sup> evaluated the essential oil activity from <i>L. sidoides</i> of the thymol (56.7&#37;)/ carvacrol (16.7&#37;) chemotype against <i>C. albicans</i>. The resulting value of the MIC was about a thousand times higher than the ketoconazole value. Oliveira <i>et al.</i><sup>8</sup> showed the activity of the thymol (18.5&#37;)/carvacrol (38.6&#37;) chemotype of <i>L. origanoides</i> essential oil against <i>Candida</i> species. In contrast, in the present study <i>A. fumigatus</i> was more sensitive to essential oils of <i>L. origanoides</i> than <i>Candida</i> species. The most active oil with content of thymol (54.5&#37;) and carvacrol (1.7&#37;) showed a MIC value against <i>A. fumigatus</i> about ten times higher than the Amphotericin B value. Interestingly, the 6F oil obtained by extraction for 15 min and with the highest thymol concentration was less active than 7G oil obtained of the same plant by extraction for 30 min. This finding shows the importance of the percentage composition of components of oils.    <br> To determine the contribution of each major component to <i>L. origanoides</i> oil activity, the antifungal activity of the thymol, carvacrol, <i>p</i>-cymene, <i>trans</i>-beta-caryophyllene, gamma-terpinene and beta-myrcene were evaluated. The lack of activity of <i>p</i>-cymene and gamma-terpinene is in agreement with previous studies<sup>19</sup>. However, Tampieri <i>et al.</i><sup>20</sup> reported that monoterpenes as gammaterpinene, <i>p</i>-cymene and carvacrol displayed good antifungal activity at 100 &mu;g ml-1 against <i>C. albicans</i>. In our study, only thymol and carvacrol were active against the fungi evaluated, however, their MIC values were higher than those found for the 3C and 7G oils.    ]]></body>
<body><![CDATA[<br> It is difficult to attribute the activity of a complex mixture as it is an essential oil to some particular constituent. Therefore, to confirm the correlation of oil activity with the percentage&#95;of their major components in situ, in a Cox model, percentage composition of the major components of the oil were screened to evaluate a possible relationship with oil antifungal activity. Thymol and carvacrol were the major components that were more closely associated with oil antifungal activity for <i>Candida</i> species. However, for species of <i>Aspergillus fumigatus</i> these analyses suggest that there is a concentration-dependent effect among the monoterpenes thymol, carvacrol, and <i>p</i>-cymene.    <br> <i>A. fumigatus</i> is the most prevalent species in the genus and it is most commonly associated to invasive aspergillosis<sup>21</sup>. In our study, essential oils from Boyac&aacute;-Colombia <i>L. origanoides</i> have shown a marked antifungal activity against <i>A. fumigatus</i> and their activity could give a new added value to these natural products. Essential oil from Boyac&aacute;-Colombia <i>L. origanoides</i> is promising candidate to evaluate their gaseous contact activity against filamentous fungi and could be employed to sterilize hospital rooms of immunosuppressant patients.</p>      <p align="center"><font size="3"><b>ACKNOWLEDGMENTS</b></font></p>      <p align="justify">Financial support from COLCIENCIAS, Bogot&aacute;, Colombia (Grant RC 432-2004 and 245-2011) is gratefully acknowledged.</p>      <p align="center"><font size="3"><b>ETHICAL CONSIDERATIONS</b></font></p>      <p align="justify">Ethical compliance is not applicable to this study.</p>      <p align="center"><font size="3"><b>CONFLICT OF INTEREST</b></font></p>      <p align="justify">The authors have no conflicts of interest to declare. Liliana Amparo Betancur Galvis certify that: The manuscript represents valid work and that neither this manuscript nor one with substantially similar content has been published under my responsibility or is being considered for publication elsewhere. There are no financial interests in relation to this manuscript. All material and financial support for this work is clearly expressed in the manuscript.</p>      <p align="center"><font size="3"><b>REFERENCES</b></font></p>      <!-- ref --><p align="justify">1. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521-526.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000062&pid=S0121-0807201100020000500001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">2. Espinel-Ingroff A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005- 2009). Rev Iberoam Micol 2009; 26: 15-22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000063&pid=S0121-0807201100020000500002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">3. Krcmery V, Barnes AJ. Non-albicans <i>Candida</i> spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-260.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000064&pid=S0121-0807201100020000500003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">4. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569-574.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000065&pid=S0121-0807201100020000500004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">5. Hennebelle T, Sahpaz S, Joseph H, Bailleul F. Ethnopharmacology of <i>Lippia alba</i>. J Ethnopharmacol 2008; 116: 211-222.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000066&pid=S0121-0807201100020000500005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">6. Rosato A, Vitali C, Gallo D, Balenzano L, Mallamaci R. The inhibition of <i>Candida</i> species by selected essential oils and their synergism with amphotericin B. Phytomedicine 2008; 15: 635-638.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000067&pid=S0121-0807201100020000500006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">7. Pascual ME, Slowing K, Carretero E, Sanchez Mata D, Villar A. <i>Lippia</i>: traditional uses, chemistry and pharmacology: a review. J Ethnopharmacol 2001; 76: 201-214.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000068&pid=S0121-0807201100020000500007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">8. Oliveira DR, Leitao GC, Bizzo HR, Alviano DS, Alviano CS, Leit&atilde;o SG. Chemical and antimicrobial analysis of essential oil of <i>Lippia origanoides</i> H.B.K. Food Chemistry 2007; 101; 236-240.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000069&pid=S0121-0807201100020000500008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">9. Garcia-Barriga H. Plantas Medicinales de Colombia, In: Anonymous. Universidad Nacional de Colombia, Bogota. 1974: 506.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000070&pid=S0121-0807201100020000500009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">10. Van Vuuren SF, Suliman S, Viljoen AM. The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials. Lett Appl Microbiol 2009; 48: 440- 446.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000071&pid=S0121-0807201100020000500010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">11. Stashenko EE, Jaramillo BE, Martinez JR. Comparison of different extraction methods for the analysis of volatile secondary metabolites of <i>Lippia alba</i> (Mill.) N.E. Brown, grown in Colombia, and evaluation of its in vitro antioxidant activity. J Chromatogr A 2004; 1025: 93-103.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000072&pid=S0121-0807201100020000500011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">12. Mesa-Arango AC, Montiel-Ramos J, Zapata B, Dur&aacute;n C, Betancur-Galvis L, Stashenko E. Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. Brown: composition, cytotoxicity and antifungal activity. Mem Inst Oswaldo Cruz. 2009; 104(6): 878-84.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000073&pid=S0121-0807201100020000500012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard. NCCLS document M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA. 2002.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000074&pid=S0121-0807201100020000500013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">14. Cuenca-Estrella M., Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, Donnelly JP, Dromer F, Dupont B, Rex JH, Richardson MD, Sancak B, Verweij PE, Rodriguez-Tudela JL. AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFSTEUCAST). Clin Microbiol Infect 2003; 9: 467-474.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000075&pid=S0121-0807201100020000500014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">15. Rojas J, Morales A, Pasquale S, M&aacute;rquez A, Rond&oacute;n M, Veres K, M&aacute;th&eacute; I. Comparative study of the chemical composition of the essential oil of <i>Lippia oreganoides</i> collected in two different seasons in Venezuela. Natural Product Communications 2006; 1; 205-207.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000076&pid=S0121-0807201100020000500015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">16. Stashenko E, Ruiz C, Mu&ntilde;oz A, Casta&ntilde;eda M, Mart&iacute;nez J. Composition and Antioxidant activity of Essential Oils of Lippia origanoides H.B.K. grown in Colombia. Nat Products Comm 2008; 3: 563-566.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000077&pid=S0121-0807201100020000500016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">17. Duarte MC, Figueira GM, Sartoratto A, Rehder VL, Delarmelina C. Anti-<i>Candida</i> activity of Brazilian medicinal plants. J Ethnopharmacol 2005; 97: 305- 311.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000078&pid=S0121-0807201100020000500017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">18. Botelho MA, Nogueira NAP, Bastos GM, Fonseca SGC, Lemos TLG, Matos FJA, Montenegro D, Heukelbach J, Rao VS, Brito GAC. Antimicrobial activity of the essential oil from <i>Lippia sidoides</i>, carvacrol and thymol against oral pathogens. Braz J Med Biol Res 2007; 40: 349-356.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000079&pid=S0121-0807201100020000500018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">19. Cosentino S, Tuberoso CI, Pisano B, Satta M, Mascia V, Arzedi E, Palmas F. In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett Appl Microbiol 1999; 29: 130-135.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000080&pid=S0121-0807201100020000500019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">20. Tampieri MP, Galuppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I. The inhibition of <i>Candida albicans</i> by selected essential oils and their major components. Mycopathologia 2005; 159: 339-345.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000081&pid=S0121-0807201100020000500020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify">21. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S0121-0807201100020000500021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nucci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Marr]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Emerging fungal diseases]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2005</year>
<volume>41</volume>
<page-range>521-526</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinel-Ingroff]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005- 2009)]]></article-title>
<source><![CDATA[Rev Iberoam Micol]]></source>
<year>2009</year>
<volume>26</volume>
<page-range>15-22</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krcmery]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance]]></article-title>
<source><![CDATA[J Hosp Infect]]></source>
<year>2002</year>
<volume>50</volume>
<page-range>243-260</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Hajjeh]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Recent trends in the epidemiology of invasive mycoses]]></article-title>
<source><![CDATA[Curr Opin Infect Dis]]></source>
<year>2002</year>
<volume>15</volume>
<page-range>569-574</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hennebelle]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sahpaz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Joseph]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bailleul]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Ethnopharmacology of Lippia alba]]></article-title>
<source><![CDATA[J Ethnopharmacol]]></source>
<year>2008</year>
<volume>116</volume>
<page-range>211-222</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosato]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vitali]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Balenzano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mallamaci]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The inhibition of Candida species by selected essential oils and their synergism with amphotericin B]]></article-title>
<source><![CDATA[Phytomedicine]]></source>
<year>2008</year>
<volume>15</volume>
<page-range>635-638</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pascual]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Slowing]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Carretero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez Mata]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Villar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Lippia: traditional uses, chemistry and pharmacology: a review]]></article-title>
<source><![CDATA[J Ethnopharmacol]]></source>
<year>2001</year>
<volume>76</volume>
<page-range>201-214</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Leitao]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Bizzo]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Alviano]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Alviano]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Leitão]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chemical and antimicrobial analysis of essential oil of Lippia origanoides H.B.K.]]></article-title>
<source><![CDATA[Food Chemistry]]></source>
<year>2007</year>
<volume>101</volume>
<page-range>236-240</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Barriga]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Plantas Medicinales de Colombia]]></article-title>
<source><![CDATA[]]></source>
<year>1974</year>
<page-range>506</page-range><publisher-loc><![CDATA[Bogota ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Vuuren]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Suliman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Viljoen]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials]]></article-title>
<source><![CDATA[Lett Appl Microbiol]]></source>
<year>2009</year>
<volume>48</volume>
<page-range>440- 446</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Jaramillo]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of different extraction methods for the analysis of volatile secondary metabolites of Lippia alba (Mill.) N.E. Brown, grown in Colombia, and evaluation of its in vitro antioxidant activity]]></article-title>
<source><![CDATA[J Chromatogr A]]></source>
<year>2004</year>
<volume>1025</volume>
<page-range>93-103</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mesa-Arango]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Montiel-Ramos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Durán]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Betancur-Galvis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. Brown: composition, cytotoxicity and antifungal activity]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2009</year>
<volume>104</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>878-84</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>National Committee for Clinical Laboratory Standards</collab>
<source><![CDATA[Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved Standard]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Wayne^ePA. PA.]]></publisher-loc>
<publisher-name><![CDATA[National Committee for Clinical Laboratory Standards]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuenca-Estrella]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Barchiesi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bille]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chryssanthou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Denning]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Donnelly]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Dromer]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dupont]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rex]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Sancak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Verweij]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez-Tudela]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing: Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFSTEUCAST)]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2003</year>
<volume>9</volume>
<page-range>467-474</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pasquale]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Márquez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rondón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Veres]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Máthé]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparative study of the chemical composition of the essential oil of Lippia oreganoides collected in two different seasons in Venezuela]]></article-title>
<source><![CDATA[Natural Product Communications]]></source>
<year>2006</year>
<volume>1</volume>
<page-range>205-207</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stashenko]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Composition and Antioxidant activity of Essential Oils of Lippia origanoides H.B.K. grown in Colombia]]></article-title>
<source><![CDATA[Nat Products Comm]]></source>
<year>2008</year>
<volume>3</volume>
<page-range>563-566</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Figueira]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Sartoratto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rehder]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Delarmelina]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Anti-Candida activity of Brazilian medicinal plants]]></article-title>
<source><![CDATA[J Ethnopharmacol]]></source>
<year>2005</year>
<volume>97</volume>
<page-range>305- 311</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Botelho]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[NAP]]></given-names>
</name>
<name>
<surname><![CDATA[Bastos]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[SGC]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[TLG]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[FJA]]></given-names>
</name>
<name>
<surname><![CDATA[Montenegro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Heukelbach]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[Brito]]></surname>
<given-names><![CDATA[GAC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens]]></article-title>
<source><![CDATA[Braz J Med Biol Res]]></source>
<year>2007</year>
<volume>40</volume>
<page-range>349-356</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cosentino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tuberoso]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Pisano]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Satta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mascia]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Arzedi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Palmas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils]]></article-title>
<source><![CDATA[Lett Appl Microbiol]]></source>
<year>1999</year>
<volume>29</volume>
<page-range>130-135</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tampieri]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Galuppi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Macchioni]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Carelle]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Falcioni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cioni]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Morelli]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The inhibition of Candida albicans by selected essential oils and their major components]]></article-title>
<source><![CDATA[Mycopathologia]]></source>
<year>2005</year>
<volume>159</volume>
<page-range>339-345</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latge]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aspergillus fumigatus and aspergillosis]]></article-title>
<source><![CDATA[Clin Microbiol Rev]]></source>
<year>1999</year>
<volume>12</volume>
<page-range>310-350</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
